Biotech entity

Himanshu Baid

Person

pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Adani Total Gas, the most common co-covered peer. At 7, the average consequence score sits above the same-window beat average of 6.

Last mentioned: Mar 12, 2026

Entity pulse

Recent coverage · Himanshu Baid

1 story
7 avg impact
0% positive
100% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.

  • 100% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Himanshu Baid

pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Adani Total Gas, the most common co-covered peer. At 7, the average consequence score sits above the same-window beat average of 6. They are less corroborated than the beat average, carrying 2 original sources each against 3.6 for the same window. We currently track 1 Biotech story that mention Himanshu Baid, all published on March 12, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 22 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Himanshu Baid. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Industry Warning

    Polymedicure and industry experts warn of imminent shortages for syringes and IV bags.

  2. Gas Rationing Implemented

    Adani Total Gas limits supply to 40% of contracted quantity for medical device producers.

  3. Price Surge Acceleration

    Raw material costs spike 25-35% within a 10-day window following escalated conflict.

  4. Initial Price Creep

    Polypropylene prices begin a steady climb as Middle East tensions simmer.

Stories mentioning Himanshu Baid 1

Pharma Negative

India Medical Device Crisis: Polypropylene Costs Soar Amid Iran Conflict

A critical shortage of medical consumables is looming in India as the Iran war triggers a 35% surge in polypropylene prices and severe gas rationing. These disruptions threaten the production of essential items like syringes and IV bags, primarily impacting the small and medium enterprises that dominate the sector.

2 sources

Himanshu Baid is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.